Class 4 Caution in Use
Vygoris Limited has informed the MHRA that some vials of Mitocin 20mg powder for solution for injection/infusion or intravesical use may contain subvisible particles above the current specifications after reconstitution (>10µm: NMT 6000/vial), initially identified during stability studies. Vygoris Limited has confirmed that a single-use filtration device called the Millex® HV (0.45 μm/PVDF) - Syringe Filter will be included in each delivery of the product
Pip code | Product description | Supplier | Batch numbers |
ALLIANCE DO NOT STOCK | MITOCIN (MITOMYCIN) 20MG POWDER FOR SOLUTION FOR INJECTION/INFUSION | VYGORIS LIMITED | 0-20071AB 0-20081AB 0-20102AB 0-20112AA 0-20042AA 0-20013AD |
This is a caution in use only we are not accepting stock returns.
Further Information
For medical information queries, please contact:
Lucy Owen,
ProductLifeGroup
Tel: +44 (0) 1223 402660
Email: lowen@productlife-group.com
For more information or stock control queries, please contact:
Hussain Tahan
Vygoris Ltd
Tel: 020 3865 1682
Email: qualitylimited@vygoris.com
If you have any questions, then please contact your local Service Centre Customer Services team